Showing results (1071-1080 of 1,368) with videos related to
Sort By:
Pageof 137
Journal of Agricultural and Food Chemistry|July 21, 2024
Discovery Phase Agrochemical Predictive Safety Assessment Using High Content <i>In Vitro</i> Data to Estimate an <i>In Vivo</i> Toxicity Point of DepartureEnrica Bianchi, Eduardo Costa, Joshua Harrill, et al.The Oncologist|June 7, 2023
Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell LymphomaCesar A Virgen, Jeffrey A Sparks, Anju Nohria, et al.Diagnostics (Basel, Switzerland)|September 9, 2023
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric ExperienceFlaminia Bellisario, Fabia Attili, Fabrizia Campana, et al.Veterinary Microbiology|August 17, 2016
Molecular surveillance of traditional and emerging pathogens associated with canine infectious respiratory diseaseNicola Decaro, Viviana Mari, Vittorio Larocca, et al.Haematologica|December 29, 1998
Ultrasound-guided core-needle biopsy is effective in the initial diagnosis of lymphoma patientsP L Zinzani, A Colecchia, D Festi, et al.Journal of Innovation in Health Informatics|November 7, 2018
Who adopts a patient portal?: An application of the diffusion of innovation modelSrinivas Emani, Ellen Peters, Sonali Desai, et al.Platelets|March 26, 2015
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndromeLuigi M Larocca, Paula G Heller, Gianmarco Podda, et al.BMC Public Health|November 16, 2021
Global trends and predictors of face mask usage during the COVID-19 pandemicElena Badillo-Goicoechea, Ting-Hsuan Chang, Esther Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomasA Cingolani, R Gastaldi, L Fassone, et al.American Journal of Hematology|April 14, 2020
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltratePaolo Milani, Francesca Fazio, Marco Basset, et al.Pageof 137